Amlodipine besylate and Olmesartan medoxomil
These highlights do not include all the information needed to use AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLETS safely and effectively. See full prescribing information for AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLETS. AMLODIPINE and OLMESARTAN MEDOXOMIL tablets, for oral use Initial U.S. Approval: 2007
69fa6293-b10a-4473-ab9b-1bd53f099bdd
HUMAN PRESCRIPTION DRUG LABEL
Dec 1, 2023
Ajanta Pharma USA Inc.
DUNS: 557554156
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Amlodipine besylate and Olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Amlodipine besylate and Olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Amlodipine besylate and Olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Amlodipine besylate and Olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
